Business
ONWARD Medical Announces First Participant Enrolled in Global Pivotal Study Evaluating ARC-IM System to Address Blood Pressure Instability After Spinal Cord Injury
Empower BP is a landmark global pivotal study evaluating the safety and effectiveness of the implantable ARC-IM® System to address blood pressure instability after spinal cord injury (SCI)Blood pressure instability is a key unmet need after SCI, with a significant impact on cardiovascular health and quality of lifeThe first participant was enrolled at Craig Hospital in Denver, Colorado, USA EINDHOVEN, the Netherlands, Feb. 04, 2026 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD and US O
About this update from Onward Medical N.v.
[{"type":"image","alt":"ONWARD Medical NV","displaySize":"","headline":null,"caption":"ONWARD Medical NV","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":150,"url":"https://media.zenfs.com/en/globenewswire.com/ff435d5a4437f6b633ad80dab68096d0"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/CPLGUw1yVOurWsVIgzW3oQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTIxMDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/ff435d5a4437f6b633ad80dab68096d0","width":300,"height":150}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"Empower BP is a landmark global pivotal study evaluating the safety and effectiveness of the implantable ARC-IM® System to address blood pressure instability after spinal cord injury (SCI)","length":188,"tagName":"p"}]},{"val":[{"type":"text","content":"Blood pressure instability is a key unmet need after SCI, with a significant impact on cardiovascular health and quality of life","length":128,"tagName":"p"}]},{"val":[{"type":"text","content":"The first participant was enrolled at Craig Hospital in Denver, Colorado, USA","length":77,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":393,"olType":false},{"type":"text","content":"EINDHOVEN, the Netherlands, Feb. 04, 2026 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD and US OTCQX: ONWRY), the neurotechnology company pioneering spinal cord stimulation therapies to restore movement, function, and independence, today announces the enrollment of the first participant in Empower BP, a global pivotal study assessing the safety and effectiveness of the investigational ARC-IM® System in managing symptomatic blood pressure instability in people with chronic spinal cord injury (SCI).","length":512,"tagName":"p"},{"type":"text","content":"Empower BP is the first global pivotal study to evaluate the Company’s implantable spinal cord stimulation system. The randomized, double-blinded, sham-controlled study is expected to involve participants across approximately 20 leading neurorehabilitation and neurosurgical research centers in the US, Canada, France, Germany, Spain, and the UK. The study targets individuals with injuries at spinal cord levels C2-T6 and injury severities of AIS A-D. The first participant was enrolled at Craig Hospital in Denver, Colorado.","length":526,"tagName":"p"},{"type":"text","content":"“The initiation...